In This Section

Division for Cancer Pharmacology – Young Investigators Symposium

Monday April 23, 2018

3:30 pm - 6:00 pm Eastern Time (ET)

Room 15B


Chair :

Christine Canman
University of Michigan Medical School

Jack Yalowich
Ohio State University

This session showcases abstract-based oral presentations by graduate student and postdoctoral ASPET members focused on cancer pharmacology.


Shu Wiley - University of California, San Diego

GPR68, A Proton Sensing GPCR, Mediates Interaction of Pancreatic Cancer Associated Fibroblasts and Cancer Cells

Tawna Whited - Case Western Reserve University

Deciphering the Role of SLX4IP in Telomere Maintenance Mechanisms

Megan Zavorka Thomas - The Ohio State University

S100A8 and S100A9 Proteins in Tyrosine Kinase Inhibitor Resistance in FLT3-ITD-Positive Acute Myeloid Leukemia

Jessica Waninger - University of Michigan Ann Arbor

Structural Characterization of KRAS with a Novel Interactor, Argonaute 2

Joseph Jilek - University of California, Davis

Bioengineered let-7c is Effective at Reducing Orthotopic Hepatocellular Carcinoma Tumor Burden and is Well Tolerated in Mouse Models

Rebecca Crawford - St Jude Children's Research Hospital

Genetic Ablation of the ABC Transporter Abcc4 Impairs Lymphoid Leukemogenesis

Wen An Pan - University of California, San Diego

Tumor Suppressor Alpha-arrestin ARRDC3 Controls GPCR Signaling and Breast Cancer Chemoresistance